The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
Phones:
+7 (495) 482-4118
+7 (495) 482-4329
  • Toll-free number for subscriptions:
    +8 800 250-18-12
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kutlubaev M.A.

Nevrologicheskoe otdelenie Respublikanskoĭ klinicheskoĭ bol'nitsy im. G.G. Kuvatova

Pal’chun V.T.

Savelieva E.E.

Kafedra otorinolaringologii s kursom IPO Bashkirskogo gosudarstvennogo meditsinskogo universiteta, Ufa;
Ufimskiĭ filial FGU "Nauchno-klinicheskiĭ tsentr otorinolaringologii FMBA Rossii"

Guseva A.L.

Pirogov Russian National Research Medical University, Moscow

Vascular mechanisms in Meniere’s disease

Authors:

Kutlubaev M.A., Pal’chun V.T., Savelieva E.E., Guseva A.L.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2019;84(2): 70‑77

DOI: 10.17116/otorino20198402170

Read: 5149 times

Contact the author
Table of contents

VASCULAR MECHANISMS IN MENIERE’S DISEASE
VASCULAR MECHANISMS IN MENIERE’S DISEASE

To cite this article:

Kutlubaev MA, Pal’chun VT, Savelieva EE, Guseva AL. Vascular mechanisms in Meniere’s disease. Russian Bulletin of Otorhinolaryngology. 2019;84(2):70‑77. (In Russ.)
https://doi.org/10.17116/otorino20198402170

Подписка 2026 Вестник оториноларингологии (Russian Bulletin of Otorhinolaryngology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Endaural phonoelectrophoresis with dexa­methasone in the treatment of Meniere’s disease. Russian Bulletin of Otorhinolaryngology. 2025;(6):19-23
Vascular endo­thelial growth factor in episodic and chro­nic migraine: new approaches to unde­rstanding pathogenesis. Russian Journal of Pain. 2025;(3):17-21
The Central Sensitization Inve­ntory: modi­fication for tension-type headache, migraine and cervicogenic headache. Russian Journal of Pain. 2025;(3):22-32
Orexin A in migraine: asso­ciations with clinical features of disease and como­rbid diso­rders. Russian Journal of Pain. 2025;(3):42-51
Clinical and labo­ratory characteristics of migraine asso­ciated with anti­phospholipid syndrome and gene­tic thro­mbophilia. Russian Journal of Pain. 2025;(3):52-57
The role of TRP channels in migraine. Russian Journal of Pain. 2025;(3):93-103
Epidemiology and some clinical aspe­cts of primary headaches in children and adolescents. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):28-35
The Neck Disa­bility Index: modi­fication of the “Driving” item of the Russian language version. Russian Journal of Pain. 2025;(4):35-42
Mal de Débarquement Syndrome — a poorly unde­rstood and rare condition in clinical practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12):200-207
Migraine: issues of pathogenesis and drug therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(1):45-52
Abstract:

Meniere’s disease (MD) is chronic multifactorial medical condition caused by endolymphatic hydrops, which etiology is unclear. This review highlights possible vascular mechanisms of MD. Impairment of vascular regulation, further ischemic damage of labyrinth and venous drainage pathology could lead to endolymphatic hydrops. Epidemiologic studies reveal high comorbidity of MD and migraine. Both diseases could be the result of trigeminovascular dysfunction. Betahistine, the medication with vascular effect, is widely used in treatment of MD, the effectiveness of calcium channel blockers is evaluated. Keywords: vertigo, Meniere’s disease, endolymphatichydrops, migraine, vascular mechanisms, betahistine.

Authors:

Kutlubaev M.A.

Nevrologicheskoe otdelenie Respublikanskoĭ klinicheskoĭ bol'nitsy im. G.G. Kuvatova

Pal’chun V.T.

Savelieva E.E.

Kafedra otorinolaringologii s kursom IPO Bashkirskogo gosudarstvennogo meditsinskogo universiteta, Ufa;
Ufimskiĭ filial FGU "Nauchno-klinicheskiĭ tsentr otorinolaringologii FMBA Rossii"

Guseva A.L.

Pirogov Russian National Research Medical University, Moscow

Close metadata

References:

  1. Lopez-Escamez JA, Carey J, Chung WH, Goebel JA, Magnusson M, Mandalà M, Newman-Toker DE, Strupp M, Suzuki M, Trabalzini F, Bisdorff A. Diagnostic criteria for Menière’s disease. Consensus document of the Bárány Society, the Japan Society for Equilibrium Research, the European Academy of Otology and Neurotology (EAONO), the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) and the Korean Balance Society. Acta Otorrinolaringol Esp. 2016;67(1):1-7. https://doi.org/10.1016/j.otorri.2015.05.005
  2. Alexander TH, Harris JP. Current epidemiology of Meniere’s syndrome. Otolaryngol Clin North Am. 2010;43(5):965-970. https://doi.org/10.1016/j.otc.2010.05.001
  3. Menière P. Pathologie auriculaire: mèmoires sur des lèsions de l’oreille interne donnant lieu des symptoms des congestion cèrèbrale apoplectiforme. Gaz Med Paris. 1861;16:597-601.
  4. Fitzgerald DC. Kyoshiro Yamakawa, MD, and temporal bone histopathology of Meniere’s patient reported in 1938. Arch Otolaryngol Head Neck Surg. 1993;119(12):1383.
  5. Hallpike CS, Cairns H. Observations on the pathology of Mènière’s syndrome. J Laryngol Otol. 1938;53:625-655.
  6. Lawrence M, McCabe B.F. Inner-ear mechanics and deafness. Special consideration of Meniere’s syndrome. J Am Med Assoc. 1959;171:1927-1932.
  7. Gürkov R. Menière and Friends: Imaging and Classification of Hydropic Ear Disease. Otol Neurotol. 2017;38(10):539-544. https://doi.org/10.1097/MAO.0000000000001479
  8. Ito T, Kitahara T, Inui H, Miyasaka T, Kichikawa K, Ota I, Nario K, Matsumura Y, Yamanaka T.Endolymphatic space size in patients with Meniere’s disease and healthy controls. Acta Otolaryngol. 2016;136(9):879-882. https://doi.org/10.3109/00016489.2016.1169556
  9. Foster CA, Breeze RE. Endolymphatic hydrops in Ménière’s disease: cause, consequence, or epiphenomenon? Otol Neurotol. 2013;34(7):1210-1214. https://doi.org/10.1097/MAO.0b013e31829e83df
  10. Cimmerman GS. Uho i mozg. M.: Medicina; 1967. (In Russ.)
  11. Friis M, Sørensen MS, Qvortrup K. The vein of the vestibular aqueduct with potential pathologic perspectives. Otol Neurotol. 2008;29(1):73-78. https://doi.org/10.1097/mao.0b013e31815c4d68
  12. Zhukovich AV. Chastnaya otonevrologiya. M.: Medicina; 1966. (In Russ.)
  13. Derebery MJ. Allergic and immunologic aspects of Meniere’s disease. Otolaryngol Head Neck Surg. 1996;114(3):360-365.
  14. Miller JM, Ren TY, Laurikainen E, Golding-Wood D, Nuttall AL. Hydrops-induced changes in cochlear blood flow. Ann Otol Rhinol Laryngol. 1995;104(6):476-483. https://doi.org/10.1177/000348949510400611
  15. Brechtelsbauer PB, Ren TY, Miller JM, Nuttall AL. Autoregulation of cochlear blood flow in the hydropic guinea pig. Hear Res. 1995;89:130-136.
  16. Masutani H, Nakai Y, Kato A. Microvascular disorder of the stria vascularis in endolymphatic hydrops. Acta Otolaryngol Suppl. 1995;519:74-77.
  17. Larsen HC, Albers F, Jansson B, Angelborg C, Veldman J. Cochlear blood flow in endolymphatic hydrops. Acta Otolaryngol. 1988;106(5-6):404-408.
  18. Andrews JC, Hoover LA, Lee RS, Honrubia V. Vertigo in the hyperviscosity syndrome. Otolaryngol Head Neck Surg. 1988;98:144-149. https://doi.org/10.1177/019459988809800208
  19. Tagaya M, Yamazaki M, Teranishi M, Naganawa S, Yoshida T, Otake H, Nakata S, Sone M, Nakashima T. Endolymphatic hydrops and blood-labyrinth barrier in Meniere’s disease. Acta Otolaryngol. 2011;131(5):474-479. https://doi.org/10.3109/00016489.2010.534114
  20. Masutani H, Nakai Y, Kato A. Microvascular disorder of the stria vascularis in endolymphatic hydrops. Acta Otolaryngol Suppl. 1995;519:74-77.
  21. Kariya S, Cureoglu S, Fukushima H, Nomiya S, Nomiya R, Schachern PA, Nishizaki K, Paparella MM. Vascular findings in the stria vascularis of patients with unilateral or bilateral Ménière’s disease: a histopathologic temporal bone study. Otol Neurotol. 2009;30(7):1006-1012. https://doi.org/10.1097/MAO.0b013e3181b4ec89
  22. Pirodda A, Brandolini C, Raimondi MC, Ferri GG, Modugno GC, Borghi C. Ménière’s disease: update of aetiopathogenetic theories and proposal of a possible model of explanation. Acta Clin Belg. 2010;65:170-175.
  23. Friberg U, Rask-Andersen H. Vascular occlusion in the endolymphatic sac in Meniere’s disease. Ann Otol Rhinol Laryngol. 2002;111(3 Pt 1):237-245. https://doi.org/10.1177/000348940211100308
  24. Sagalovich BM, Pal’chun VT. Bolezn ’ Men’era. M.: MiA; 1999. (In Russ.)
  25. Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A, Golubnitschaja O, Erb C, Reitsamer HA, Kida T, Kurysheva N, Yao K. Flammer syndrome. EPMA J. 2014;5(1):11. https://doi.org/10.1186/1878-5085-5-11
  26. Gortan D. Transcranial Doppler sonography in patients with Meniére’s disease. Acta Med Croatica. 2000;54(1):11-14.
  27. Friis M, Sørensen MS, Qvortrup K. The vein of the vestibular aqueduct with potential pathologic perspectives. Otol Neurotol. 2008;29(1):73-78. https://doi.org/10.1097/mao.0b013e31815c4d68.
  28. Filipo R, Ciciarello F, Attanasio G, Mancini P, Covelli E, Agati L, Fedele F, Viccaro M. Chronic cerebrospinal venous insufficiency in patients with Ménière’s disease. Eur Arch Otorhinolaryngol. 2015;272(1):77-82. https://doi.org/10.1007/s00405-013-2841-1.
  29. Di Berardino F, Alpini DC, Bavera PM, Cecconi P, Farabola M, Mattei V, Ambrosetti U, Cesarani A. Chronic cerebrospinal venous insufficiency in Ménière disease. Phlebology. 2015;30(4):274-279. https://doi.org/10.1177/0268355514526871
  30. Redfern RE, Brown M, Benson AG. High jugular bulb in a cohort of patients with definite Ménière’s disease. J Laryngol Otol. 2014;128(9):759-764. https://doi.org/10.1017/S0022215114001820
  31. Park JJ, Shen A, Keil S, Kuhl C, Westhofen M. Jugular bulb abnormalities in patients with Meniere’s disease using high-resolution computed tomography. Eur Arch Otorhinolaryngol. 2015;272(8):1879-1884. https://doi.org/10.1007/s00405-014-2996-4
  32. Bruno A, Napolitano M, Califano L, Attanasio G, Giugliano V, Cavazzuti PP, Viccaro M, Masci E, Mastrangelo D, Salafia F, Mazzone S, Bernardo B, Cagnoni L, Filipo R, De Vincentis M, Greco A. The Prevalence of Chronic Cerebrospinal Venous Insufficiency in Meniere Disease: 24-Month Follow-up after Angioplasty. J Vasc Interv Radiol. 2017;28(3):388-391. https://doi.org/10.1016/j.jvir.2016.10.019
  33. Lempert T, Olesen J, Furman J, Waterston J, Seemungal B, Carey J, Bisdorff A, Versino M, Evers S, Newman-Toker D. Vestibular migraine: diagnostic criteria. J Vestib Res. 2012;22(4):167-172. https://doi.org/10.3233/VES-2012-0453
  34. Headache Classification Committee of the International Headache Society (IHS) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629-808. https://doi.org/10.1177/0333102413485658
  35. Formeister EJ, Rizk HG, Kohn MA, Sharon JD. The Epidemiology of Vestibular Migraine: A Population-based Survey Study. Otol Neurotol. 2018;39(8):1037-1044. https://doi.org/10.1097/MAO.0000000000001900
  36. Hwang JH, Tsai SJ, Liu TC, Chen YC, Lai JT. Association of Tinnitus and Other Cochlear Disorders With a History of Migraines. JAMA Otolaryngol Head Neck Surg. 2018;144(8):712-717. https://doi.org/10.1001/jamaoto.2018.0939
  37. Kunel’skaia NL, Tardov MV, Baibakova EV, Chugunova MA, Zaoeva ZO. Cochleovestibular disorders in the patients suffering from migraine of the basilar type. Vestnik otorinolaringologii. 2014;6:20-23. (In Russ.) https://doi.org/10.17116/otorino2014620-23
  38. Radtke A, Neuhauser H, von Brevern M, Hottenrott T, Lempert T. Vestibular migraine — validity of clinical diagnostic criteria. Cephalalgia. 2011;31(8):906-913. https://doi.org/10.1177/0333102411405228
  39. Neff BA, Staab JP, Eggers SD, Carlson ML, Schmitt WR, Van Abel KM, Worthington DK, Beatty CW, Driscoll CL, Shepard NT. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Ménière’s disease, vestibular migraine, and Ménière’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33(7):1235-1244. https://doi.org/10.1097/MAO.0b013e31825d644a
  40. Vass Z, Shore SE, Nuttall AL, Miller JM. Endolymphatic hydrops reduces retrograde labeling of trigeminal innervation to the cochlea. Exp Neurol. 1998;151(2):241-248.
  41. Shore SE, Koehler S, Oldakowski M, Hughes LF, Syed S. Dorsal cochlear nucleus responses to somatosensory stimulation are enhanced after noise-induced hearing loss. Eur J Neurosci. 2008;27(1):155-168. https://doi.org/10.1111/j.1460-9568.2007.05983.x
  42. Espinosa-Sanchez JM, Lopez-Escamez JA. New insights into pathophysiology of vestibular migraine. Front Neurol. 2015;6:12. https://doi.org/10.3389/fneur.2015.00012
  43. Ghavami Y, Mahboubi H, Yau AY, Maducdoc M, Djalilian HR. Migraine features in patients with Meniere’s disease. Laryngoscope. 2016;126(1):163-168. https://doi.org/10.1002/lary.25344
  44. Murofushi T, Tsubota M, Kitao K, Yoshimura E. Simultaneous Presentation of Definite Vestibular Migraine and Definite Ménière’s Disease: Overlapping Syndrome of Two Diseases. Front Neurol. 2018;9:749. https://doi.org/10.3389/fneur.2018.00749
  45. Chu CH, Liu CJ, Fuh JL, Shiao AS, Chen TJ, Wang SJ. Migraine is a risk factor for sudden sensorineural hearing loss: a nationwide population-based study. Cephalalgia. 2013;33(2):80-86. https://doi.org/10.1177/0333102412468671
  46. Wang CX, Wang JM. Risk factors for recurrence of benign paroxysmal positional vertigo: Meta-analysis. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018;32(17):1298-1303. https://doi.org/10.13201/j.issn.1001-1781.2018.17.003
  47. Tabet P, Saliba I. Meniere’s Disease and Vestibular Migraine: Updates and Review of the Literature. J Clin Med Res. 2017;9(9):733-744. https://doi.org/10.14740/jocmr3126w
  48. Palchun VT, Guseva AL, Chistov SD. The peculiar features of vestibular function disorders associated with Meniere’s disease. Vestnik otorinolaringologii. 2018;83(1):23-26. (In Russ.) https://doi.org/10.17116/otorino201883123-26
  49. Martin-Sanz E, Vargas Salamanca E, Marqués Cabrero A, Esteban J, Muerte I, Sanz-Fernández R. Value of clinical data and vestibular testing in a population of 101 patients with recurrent vestibulopathy. Clin Otolaryngol. 2014;39(5):311-315. https://doi.org/10.1111/coa.12287
  50. Taylor RL, Zagami AS, Gibson WP, Black DA, Watson SR, Halmagyi MG, Welgampola MS. Vestibular evoked myogenic potentials to sound and vibration: characteristics in vestibular migraine that enable separation from Meniere’s disease. Cephalalgia. 2012;32(3):213-225. https://doi.org/10.1177/0333102411434166
  51. Frejo L, Martin-Sanz E, Teggi R, Trinidad G, Soto-Varela A, Santos-Perez S, Manrique R, Perez N, Aran I, Almeida-Branco MS, Batuecas-Caletrio A, Fraile J, Espinosa-Sanchez JM, Perez-Guillen V, Perez-Garrigues H, Oliva-Dominguez M, Aleman O, Benitez J, Perez P, Lopez-Escamez JA. Meniere’s disease Consortium (MeDiC). Extended phenotype and clinical subgroups in unilateral Meniere disease: A cross-sectional study with cluster analysis. Extended phenotype and clinical subgroups in unilateral Meniere disease: A cross-sectional study with cluster analysis. Clin Otolaryngol. 2017;42(6):1172-1180. https://doi.org/10.1111/coa.12844
  52. Gürkov R, Jerin C, Flatz W, Maxwell R. Clinical manifestations of hydropic ear disease (Menière’s). Eur Arch Otorhinolaryngol. 2018. https://doi.org/10.1007/s00405-018-5157-3.
  53. Babajkova EV, Belyakova LV, Garov EV, Guseva AL, Zagorskaya EE, Zajceva OV, Karneeva OV, Kirichenko IM, Kryukov AI, Kudeeva YaYu, Kunel’skaya NL, Levina YuV, Chugunova MA, Yanyushkina EV, Mirzabekyan EV. Bolezn’ Men’era. Klinicheskie rekomendacii. Nacional’naya medicinskaya associaciya otorinolaringologov. M. 2016. (In Russ.)
  54. Boiko NV, Kunel’skaya NL. The current problems related to Meniere’s disease. Vestnik otorinolaringologii. 2016;81(5):89-93. (In Russ.) https://doi.org/10.17116/otorino201681589-93
  55. Lacour M, Sterkers O. Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action. CNS Drugs. 2001;15(11):853-870.
  56. Ihler F, Bertlich M, Sharaf K, Strieth S, Strupp M, Canis M. Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo. PLoS One. 2012;7(6):e39086. https://doi.org/10.1371/journal.pone.0039086
  57. Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M; BEMED Study Group. Efficacy and safety of betahistine treatment in patients with Meniere’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016;352:6816. https://doi.org/10.1136/bmj.h6816
  58. Lacour M. Betahistine treatment in managing vertigo and improving vestibular compensation: clarification. J Vestib Res. 2013;23(3):139-151. https://doi.org/10.3233/VES-130496
  59. Strupp M, Kraus L, Schautzer F, Rujescu D. Menière’s disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study. J Neurol. 2018;265 (suppl 1):80-85. https://doi.org/10.1007/s00415-018-8809-8.
  60. Lassen LF, Hirsch BE, Kamerer DB. Use of nimodipine in the medical treatment of Menière’s disease: clinical experience. Am J Otol. 1996;17(4):577-580.
  61. Monzani D, Barillari MR, Alicandri Ciufelli M, Aggazzotti Cavazza E, Neri V, Presutti L, Genovese E. Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière’s disease: a 10-year experience. Acta Otorhinolaryngol Ital. 2012;32(6):393-403.
  62. Pianese CP, Hidalgo LO, González RH, Madrid CE, Ponce JE, Ramírez AM, Morán LM, Arenas JE, Rubio AT, Uribe JO, Abiuso J, Hanuch E, Alegría J, Volpi C, Flaskamp R, Sanjuán AP, Gómez JM, Hernández J, Pedraza A, Quijano D, Martínez C, Castañeda JR, Guerra OJ, F GV. New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study. Otol Neurotol. 2002;23(3):357-363.
  63. Teggi R, Gatti O, Sykopetrites V, Quaglieri S, Benazzo M, Bussi M. Association of cinnarizine and betahistine in prophylactic therapy for Ménière’s disease with and without migraine. Acta Otorhinolaryngol Ital. 2014;34(5):349-353.
  64. Haid T. Evaluation of flunarizine in patients with Menière’s disease. Subjective and vestibular findings. Acta Otolaryngol Suppl. 1988;460:149-153.
  65. Ohlsén KA, Didier A, Baldwin D, Miller JM, Nuttall AL, Hultcrantz E. Cochlear blood flow in response to dilating agents. Hear Res. 1992;58(1):19-25.
  66. Sbeih F, Christov F, Gluth MB. Newly diagnosed Meniere’s disease: clinical course with initiation of noninvasive treatment including an accounting of vestibular migraine. Ann Otol Rhinol Laryngol. 2018;127(5):331-337. https://doi.org/10.1177/0003489418763224
  67. Tziridis K, Korn S, Ahlf S, Schulze H. Protective effects of Ginkgo biloba extract EGb 761 against noise trauma-induced hearing loss and tinnitus development. Neural Plast. 2014;427298. https://doi.org/10.1155/2014/427298
  68. Agus S, Benecke H, Thum C, Strupp M. Clinical and Demographic Features of Vertigo: Findings from the REVERT Registry. Front Neurol. 2013;4:48. https://doi.org/10.3389/fneur.2013.00048
  69. Foster CA. Optimal management of Ménière’s disease. Ther Clin Risk Manag. 2015;11:301-307. https://doi.org/10.2147/TCRM.S59023
  70. Sheremet AS. Dinamicheskaya harakteristika sostoyaniya funkcij vnutrennego uha pri bolezni Men’era: Dis... kand. med. nauk. M 2003. (In Russ.)
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.